Wagoner Michael D, Al-Swailem Samar A, Sutphin John E, Zimmerman M Bridgett
Department of Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Ophthalmology. 2007 Jun;114(6):1073-9. doi: 10.1016/j.ophtha.2006.10.015. Epub 2007 Feb 1.
To determine the incidence, microbiological profile, graft survival, and factors influencing graft survival after the development of bacterial keratitis after penetrating keratoplasty (PK).
Retrospective case series.
One hundred two patients (102 eyes) treated at a single center during a 5-year period.
Retrospective review of the medical records of every patient treated for culture-positive keratitis between January 1, 1998 and December 31, 2002 who previously had undergone penetrating keratoplasty at the King Khaled Eye Specialist Hospital.
Graft survival and visual outcome.
There were 2103 PKs performed and 102 (4.9%) cases of culture-positive keratitis during the study period. There were 168 bacterial isolates, of which 140 (83.3%) were gram positive, 28 (16.7%) were gram negative, and 1 (0.6%) was acid fast. Only 38 (37.3%) grafts remained clear after a mean follow-up of 985 days (range, 82-2284). The best graft survival was in eyes with PK for keratoconus (83.7%), whereas the poorest grat survival was for previously failed grafts (5.6%). By Kaplan-Meier analysis, there was an immediate steep decline in graft survival to 54.9%, followed by a slow decline to 47.2% by 1 year and 35.8% after 4 years. Factors associated with an increased risk of graft failure were the surgical indication for PK (P<0.001), increasing patient age (P = 0.004), smaller donor (P = 0.001) and recipient (P = 0.0003) graft size, history of previous microbial keratitis (P = 0.02) or endothelial rejection episodes (P = 0.02), and coexisting glaucoma (P = 0.001). The visual outcome was > or =20/40 in only 8 (8.2%) eyes and better than 20/200 in only 21 (21.6%) eyes.
The development of bacterial keratitis after PK is a serious complication that is associated with a high incidence of graft failure and poor visual outcome.
确定穿透性角膜移植术(PK)后发生细菌性角膜炎后的发病率、微生物学特征、植片存活率以及影响植片存活的因素。
回顾性病例系列研究。
在5年期间于单一中心接受治疗的102例患者(102只眼)。
回顾性分析1998年1月1日至2002年12月31日期间在哈立德国王眼科专科医院接受治疗的每例培养阳性角膜炎患者的病历,这些患者此前均接受过穿透性角膜移植术。
植片存活情况和视力结果。
在研究期间共进行了2103例穿透性角膜移植术,其中102例(4.9%)发生培养阳性角膜炎。共分离出168株细菌,其中140株(83.3%)为革兰阳性菌,28株(16.7%)为革兰阴性菌,1株(0.6%)为抗酸菌。平均随访985天(范围82 - 2284天)后,仅38只(37.3%)植片保持透明。圆锥角膜患者接受穿透性角膜移植术后的植片存活率最高(83.7%),而先前植片失败患者的植片存活率最低(5.6%)。通过Kaplan-Meier分析,植片存活率立即急剧下降至54.9%,随后缓慢下降,1年后降至47.2%,4年后降至35.8%。与植片失败风险增加相关的因素包括穿透性角膜移植术的手术指征(P<0.001)、患者年龄增加(P = 0.004)、供体(P = 0.001)和受体(P = 0.0003)植片尺寸较小、既往微生物性角膜炎病史(P = 0.02)或内皮排斥发作史(P = 0.02)以及并存青光眼(P = 0.001)。视力结果仅8只(8.2%)眼≥20/40,仅21只(21.6%)眼优于20/200。
穿透性角膜移植术后发生细菌性角膜炎是一种严重并发症,与植片失败的高发生率和不良视力结果相关。